The anti-angiogenic basis of metronomic chemotherapy - PubMed (original) (raw)

Review

doi: 10.1038/nrc1369.

Affiliations

• PMID: 15170445
• DOI: 10.1038/nrc1369

Review

The anti-angiogenic basis of metronomic chemotherapy

Robert S Kerbel et al. Nat Rev Cancer. 2004 Jun.

No abstract available

PubMed Disclaimer

Similar articles

• [A new treatment protocol targeting tumor vasculature--- metronomic chemotherapy combined radiotherapy].
  Qiu H, Wang GM. Qiu H, et al. Ai Zheng. 2007 Dec;26(12):1392-6. Ai Zheng. 2007. PMID: 18076810 Review. Chinese.
• Metronomic chemotherapy: teaching old drugs new tricks?
  Vogelzang N. Vogelzang N. Clin Adv Hematol Oncol. 2004 Jul;2(7):432-3. Clin Adv Hematol Oncol. 2004. PMID: 16163217 No abstract available.
• Metronomic chemotherapy and nanocarrier platforms.
  Abu Lila AS, Ishida T. Abu Lila AS, et al. Cancer Lett. 2017 Aug 1;400:232-242. doi: 10.1016/j.canlet.2016.11.007. Epub 2016 Nov 10. Cancer Lett. 2017. PMID: 27838415 Review.
• Angiogenesis and chemotherapy resistance: optimizing chemotherapy scheduling using mathematical modeling.
  Bodzioch M, Bajger P, Foryś U. Bodzioch M, et al. J Cancer Res Clin Oncol. 2021 Aug;147(8):2281-2299. doi: 10.1007/s00432-021-03657-9. Epub 2021 May 29. J Cancer Res Clin Oncol. 2021. PMID: 34050795 Free PMC article.
• Metronomic chemotherapy in progressive pediatric malignancies: old drugs in new package.
  Bahl A, Bakhshi S. Bahl A, et al. Indian J Pediatr. 2012 Dec;79(12):1617-22. doi: 10.1007/s12098-012-0759-z. Epub 2012 Apr 28. Indian J Pediatr. 2012. PMID: 22544675 Review.

Cited by

• Metronomic vinorelbine: Anti-angiogenic activity in vitro in normoxic and severe hypoxic conditions, and severe hypoxia-induced resistance to its anti-proliferative effect with reversal by Akt inhibition.
  Mavroeidis L, Sheldon H, Briasoulis E, Marselos M, Pappas P, Harris AL. Mavroeidis L, et al. Int J Oncol. 2015 Aug;47(2):455-64. doi: 10.3892/ijo.2015.3059. Epub 2015 Jun 19. Int J Oncol. 2015. PMID: 26095084 Free PMC article.
• Pharmacodynamic biomarkers in metronomic chemotherapy: multiplex cytokine measurements in gastrointestinal cancer patients.
  Valenzuela P, Oaxaca D, Di Desidero T, Parra K, Rodriguez G, Manciu M, Allegrini G, Falcone A, Bocci G, Kirken RA, Francia G. Valenzuela P, et al. Clin Exp Med. 2021 Feb;21(1):149-159. doi: 10.1007/s10238-020-00666-9. Epub 2020 Oct 13. Clin Exp Med. 2021. PMID: 33048259 Free PMC article.
• Metronomic chemotherapy and drug repurposing: A paradigm shift in oncology.
  Jan N, Sofi S, Qayoom H, Shabir A, Haq BU, Macha MA, Almilaibary A, Mir MA. Jan N, et al. Heliyon. 2024 Jan 14;10(3):e24670. doi: 10.1016/j.heliyon.2024.e24670. eCollection 2024 Feb 15. Heliyon. 2024. PMID: 38314272 Free PMC article. Review.
• Fine-tuning anti-tumor immunotherapies via stochastic simulations.
  Caravagna G, Barbuti R, d'Onofrio A. Caravagna G, et al. BMC Bioinformatics. 2012 Mar 28;13 Suppl 4(Suppl 4):S8. doi: 10.1186/1471-2105-13-S4-S8. BMC Bioinformatics. 2012. PMID: 22536975 Free PMC article.
• Human microbiome and prostate cancer development: current insights into the prevention and treatment.
  Ohadian Moghadam S, Momeni SA. Ohadian Moghadam S, et al. Front Med. 2021 Feb;15(1):11-32. doi: 10.1007/s11684-019-0731-7. Epub 2020 Jun 30. Front Med. 2021. PMID: 32607819 Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database